Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 27Active not recruiting 9Not yet recruiting 5Completed 4Terminated 2Withdrawn 1Suspended 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Classical hematology 5Other hematologic neoplasm 4

Conditions

Breast Neoplasms 360Neoplasms 255Carcinoma, Non-Small-Cell Lung 199Colorectal Neoplasms 183Lung Neoplasms 152Prostatic Neoplasms 151Carcinoma, Hepatocellular 128Leukemia, Myeloid, Acute 96Pancreatic Neoplasms 86Multiple Myeloma 84Neoplasm Metastasis 74Recurrence 71Uterine Cervical Neoplasms 69Rectal Neoplasms 68Stomach Neoplasms 65Ovarian Neoplasms 65Triple Negative Breast Neoplasms 60Squamous Cell Carcinoma of Head and Neck 57Head and Neck Neoplasms 54Glioblastoma 54Brain Neoplasms 54Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 50Endometrial Neoplasms 47Melanoma 44Esophageal Neoplasms 43Disease 43Colonic Neoplasms 42Hematologic Neoplasms 41Glioma 40

Interventions

treosulfan 1fludarabine 1Melphalan 1Honey 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Anemia, Refractory, with Excess of Blasts × 1 year × Clear all
NCT07607327 2026-05-26

FORWARD

CareDx

Not yet recruiting
400 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Recurrence, Leukemia, Myeloid, Acute

NCT07561385 2026-05-01

Dresden MDS Registry With an Accompanying Biomaterial Collection

Technische Universität Dresden

Not yet recruiting
500 enrolled
Classical hematology

Anemia, Refractory, with Excess of Blasts

NCT06906380 2025-12-08

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

ARCE Therapeutics, Inc.

Not yet recruiting
49 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT07214064 2025-10-09

Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation

University Hospital Tuebingen

Phase 2 Not yet recruiting
27 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

NCT07025824 2025-09-03

RELEVANT

Technische Universität Dresden

Phase 2 Not yet recruiting
220 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡